Fetal Brain Care: Therapies for Brain Neurodevelopment in Fetal Growth Restriction
Institut d'Investigacions Biomèdiques August Pi i Sunyer
304 participants
Jan 18, 2023
INTERVENTIONAL
Conditions
Summary
Singleton pregnancies being diagnosed of fetal growth restriction from 24 to 32.6 weeks of gestation will be randomized to two equally sized groups: maternal oral supplementation with Lactoferrin and DHA (Docosahexaenoic acid) or placebo.
Eligibility
Plain Language Summary
Simplified for easier understanding
This summary was AI-generated to explain the trial in plain language. It is not medical advice. Always discuss eligibility with your doctor before enrolling in a clinical trial.
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
The intervention consists in the maternal oral administration of 1000mg of Lactoferrin and 1000mg of DHA daily
Product with the same physical appearance and taste as the main intervention but without therapeutic effect
Locations(6)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT05038462